Javascript must be enabled to continue!
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in Five Gulf Countries.
View through CrossRef
Abstract
Background: The Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) was the first prospective multicenter registry conducted in five Gulf countries to explore the epidemiology of venous thromboembolic (VTE) disorders and to provide data on diagnosis and disease management.
Methods: Data on 242 patients with confirmed VTE were submitted between September 2003 and November 2003 by multidisciplinary specialists from 28 contributing hospitals in the Gulf region (Kuwait, Bahrain, Qatar, Oman, and the UAE). Patients with a suspected diagnosis of VTE were included. The data management team at a sponsor-independent study coordinating center ensured data quality. Differences between groups were assessed by the Chi square test or Fisher exact test for categorical variables. The Student t-test was used for testing proportions. A two-tailed P value <0.05 was considered significant. Doppler ultrasound and lung scans were the most preferred modalities in the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Results: The table shows the incidence of VTE. The most common symptoms of DVT and DVT/PE patients were calf pain (72%), calf swelling (63.8%), and localized tenderness (52.2%). Calf pain and localized tenderness were significantly greater (P <0.001) in cases of DVT alone than in cases of DVT/PE. The most common symptoms in patients with PE alone and DVT/PE were dyspnea (83.6%), thoracic pain (69.1%), and cough (40%). Cough and hemoptysis occurred more frequently in PE cases than in cases of DVT/PE (P <0.001). Risk factors for VTE were immobilization >3 days (41.3%), age >65 years (28.9%), a history of VTE (20.7%), and trauma (19%). Surgical intervention in the previous year was an independent risk factor for VTE, 83.8% of such patients experiencing VTE within 4 weeks of surgery. There was a strong association between VTE and orthopedic procedures (P=0.0016). Among surgical interventions, orthopedic procedures induced the greatest number of VTE cases, followed by general surgical procedures and gynecological procedures. Low molecular weight heparins (LMWHs) were chosen to treat 33.7% of DVT cases, while unfractionated heparin (UFH) was used in 21.9% of cases. UFH use in PE and DVT/PE was 57.1% and 55%, respectively, and LMWHs use was 14.3% each for PE and DVT/PE. Oral anticoagulant use in DVT/PE, DVT, and PE was 30%, 19.8%, and 2.9%, respectively.
Conclusion: The main risk factors predisposing to VTE are immobilization, age >65 years, a history of VTE, and trauma. The highest incidence was observed in medical patients, necessitating prophylaxis in patients at risk. Previous surgical interventions were independent risk factors for VTE, requiring extended prophylaxis, including outpatient thromboprophylaxis, in patients undergoing extensive surgical procedures.
Incidence of DVT, PE, and DVT/PE
DVT PE DVT/PE Frequency of cases - n (%) 187 (77.27%) 35 (14.46%) 20 (8.26%) Departments Medical 74 (39.5%) 19 (54.28%) 10 (50%) Surgical 61 (32.62%) 9 (25.71%) 6 (30%) Others 52 (27.8%) 7 (20%) 4 (20%)
American Society of Hematology
Title: Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in Five Gulf Countries.
Description:
Abstract
Background: The Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) was the first prospective multicenter registry conducted in five Gulf countries to explore the epidemiology of venous thromboembolic (VTE) disorders and to provide data on diagnosis and disease management.
Methods: Data on 242 patients with confirmed VTE were submitted between September 2003 and November 2003 by multidisciplinary specialists from 28 contributing hospitals in the Gulf region (Kuwait, Bahrain, Qatar, Oman, and the UAE).
Patients with a suspected diagnosis of VTE were included.
The data management team at a sponsor-independent study coordinating center ensured data quality.
Differences between groups were assessed by the Chi square test or Fisher exact test for categorical variables.
The Student t-test was used for testing proportions.
A two-tailed P value <0.
05 was considered significant.
Doppler ultrasound and lung scans were the most preferred modalities in the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Results: The table shows the incidence of VTE.
The most common symptoms of DVT and DVT/PE patients were calf pain (72%), calf swelling (63.
8%), and localized tenderness (52.
2%).
Calf pain and localized tenderness were significantly greater (P <0.
001) in cases of DVT alone than in cases of DVT/PE.
The most common symptoms in patients with PE alone and DVT/PE were dyspnea (83.
6%), thoracic pain (69.
1%), and cough (40%).
Cough and hemoptysis occurred more frequently in PE cases than in cases of DVT/PE (P <0.
001).
Risk factors for VTE were immobilization >3 days (41.
3%), age >65 years (28.
9%), a history of VTE (20.
7%), and trauma (19%).
Surgical intervention in the previous year was an independent risk factor for VTE, 83.
8% of such patients experiencing VTE within 4 weeks of surgery.
There was a strong association between VTE and orthopedic procedures (P=0.
0016).
Among surgical interventions, orthopedic procedures induced the greatest number of VTE cases, followed by general surgical procedures and gynecological procedures.
Low molecular weight heparins (LMWHs) were chosen to treat 33.
7% of DVT cases, while unfractionated heparin (UFH) was used in 21.
9% of cases.
UFH use in PE and DVT/PE was 57.
1% and 55%, respectively, and LMWHs use was 14.
3% each for PE and DVT/PE.
Oral anticoagulant use in DVT/PE, DVT, and PE was 30%, 19.
8%, and 2.
9%, respectively.
Conclusion: The main risk factors predisposing to VTE are immobilization, age >65 years, a history of VTE, and trauma.
The highest incidence was observed in medical patients, necessitating prophylaxis in patients at risk.
Previous surgical interventions were independent risk factors for VTE, requiring extended prophylaxis, including outpatient thromboprophylaxis, in patients undergoing extensive surgical procedures.
Incidence of DVT, PE, and DVT/PE
DVT PE DVT/PE Frequency of cases - n (%) 187 (77.
27%) 35 (14.
46%) 20 (8.
26%) Departments Medical 74 (39.
5%) 19 (54.
28%) 10 (50%) Surgical 61 (32.
62%) 9 (25.
71%) 6 (30%) Others 52 (27.
8%) 7 (20%) 4 (20%).
Related Results
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
<p dir="ltr">Individuals with rheumatoid arthritis (RA) are at around 50-100% increased risk of venous thromboembolism (VTE). In 2019, signals emerged suggesting an increased...
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
<p dir="ltr">Individuals with rheumatoid arthritis (RA) are at around 50-100% increased risk of venous thromboembolism (VTE). In 2019, signals emerged suggesting an increased...
Outcomes of Venous Thromboembolism in Hospitalized Non-Hodgkin Lymphoma Patients: Analysis from the Nationwide Inpatient Sample Database
Outcomes of Venous Thromboembolism in Hospitalized Non-Hodgkin Lymphoma Patients: Analysis from the Nationwide Inpatient Sample Database
Abstract
Introduction:
Venous Thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is one of the major caus...
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Study object: Describe the direct treatment costs due to venous thromboembolism complications 90 days after surgery by using national health insurance reimbursement database. Patie...
Predictive Efficacy of the Khorana Score in Black Patients: Retrospective Cohort Study
Predictive Efficacy of the Khorana Score in Black Patients: Retrospective Cohort Study
Background
The Khorana score(KS) is a predictive score used to determine the risk of venous thromboembolism (VTE) in cancer(CA) patients(pts). According to the origi...
Prevalence and Mortality Predictors of Venous Thromboembolism Among 48 Model Hospital Patients (2016-2020)
Prevalence and Mortality Predictors of Venous Thromboembolism Among 48 Model Hospital Patients (2016-2020)
Background: Venous thromboembolism (VTE) is the third most prevalent vascular disease, and it has a substantial impact on morbidity and mortality. Although its effectiveness, evide...
Incidence of Venous Thromboembolism in Patients with Different Classes of Obesity in Comparison to Inherited Thrombophilias
Incidence of Venous Thromboembolism in Patients with Different Classes of Obesity in Comparison to Inherited Thrombophilias
Introduction: Obesity is a significant risk factor for venous thromboembolism (VTE). It is linked to physical inactivity, increased intra-abdominal pressure, chronic inflammation, ...

